Cornea Sense
Aalto University spin-out incorporated in January 2026 developing a non-invasive diagnostic device that measures corneal hydration by combining terahertz sensing with optical coherence tomography, aimed at dry eye, post-surgical monitoring and systemic conditions such as diabetes.
Headquarters
Espoo, Finland
Year Founded
2026
Founders
Anton Chernenko (CEO), Irina Nefedova (CTO)
Country
Finland
Financial Information
Funding Stage
Pre-Seed
Recent Funding
EUR 1.1M
Funding By
Innovestor Angel CoFounder, Business Finland (grant), angel investors
Core Technology
Terahertz sensing combined with optical coherence tomography
Product Type
Medical Device
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
None disclosed
Academic / Hospital Tie-ups
Aalto University (spin-out origin)
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Objective non-invasive corneal hydration measurement where current assessment is subjective